NeoPharm CO. LTD (092730) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.031x

Based on the latest financial reports, NeoPharm CO. LTD (092730) has a cash flow conversion efficiency ratio of 0.031x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩5.88 Billion ≈ $3.98 Million USD) by net assets (₩188.40 Billion ≈ $127.68 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 092730 market cap overview for the company's overall valuation and market capitalisation.

NeoPharm CO. LTD - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how NeoPharm CO. LTD's cash flow conversion efficiency has evolved over time, based on yearly financial data.

NeoPharm CO. LTD Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of NeoPharm CO. LTD ranked by their cash flow conversion efficiency. Explore earnings quality score of NeoPharm CO. LTD to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Unic Technology TWO:5452	-0.104x
Duluth Holdings Inc NASDAQ:DLTH	0.333x
Monte Carlo Fashions Limited NSE:MONTECARLO	-0.221x
Dongsung Corporation KO:102260	-0.014x
Kunyue Development Co Ltd TWO:5206	-0.042x
Thien Viet Securities JSC VN:TVS	-0.388x
T.K.S. Technologies Public Company Limited BK:TKS	0.027x
City Lodge Hotels Ltd JSE:CLH	0.194x

Annual Cash Flow Conversion Efficiency for NeoPharm CO. LTD (2012–2024)

The table below shows the annual cash flow conversion efficiency of NeoPharm CO. LTD from 2012 to 2024. View latest NeoPharm CO. LTD stock price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩176.88 Billion ≈ $119.87 Million	₩18.63 Billion ≈ $12.63 Million	0.105x	-27.54%
2023-12-31	₩160.03 Billion ≈ $108.45 Million	₩23.26 Billion ≈ $15.76 Million	0.145x	+13.83%
2022-12-31	₩142.21 Billion ≈ $96.37 Million	₩18.16 Billion ≈ $12.31 Million	0.128x	-23.25%
2021-12-31	₩130.30 Billion ≈ $88.31 Million	₩21.68 Billion ≈ $14.69 Million	0.166x	+14.72%
2020-12-31	₩117.72 Billion ≈ $79.78 Million	₩17.07 Billion ≈ $11.57 Million	0.145x	-20.26%
2019-12-31	₩105.69 Billion ≈ $71.63 Million	₩19.22 Billion ≈ $13.03 Million	0.182x	-33.35%
2018-12-31	₩59.29 Billion ≈ $40.18 Million	₩16.18 Billion ≈ $10.96 Million	0.273x	+21.97%
2017-12-31	₩47.58 Billion ≈ $32.25 Million	₩10.65 Billion ≈ $7.21 Million	0.224x	-5.75%
2016-12-31	₩38.57 Billion ≈ $26.14 Million	₩9.16 Billion ≈ $6.21 Million	0.237x	+27.07%
2015-12-31	₩32.62 Billion ≈ $22.11 Million	₩6.09 Billion ≈ $4.13 Million	0.187x	+890.58%
2012-12-31	₩29.92 Billion ≈ $20.28 Million	₩564.34 Million ≈ $382.45K	0.019x	--

About NeoPharm CO. LTD

KQ:092730 Korea Personal & Household Products & Services

Market Cap

$124.25 Million

₩183.34 Billion KRW

Market Cap Rank

#18463 Global

#832 in Korea

Share Price

₩22950.00

Change (1 day)

+5.52%

52-Week Range

₩15760.00 - ₩25450.00

All Time High

₩27383.15